期刊文献+

左心室射血分数正常心力衰竭患者临床分析 被引量:4

Analysis of cardiac failure patients with normal left ventricular ejection fraction
下载PDF
导出
摘要 目的:探讨心力衰竭(CHF)患者左心室射血分数(LVEF)≥40%与<40%的临床比较差异,并评价相关影响因素。方法:选择心功能不全临床体征符合NYHA分级Ⅱ~Ⅳ级的患者100例,LVEF≥40%为观察组,LVEF<40%为对照组,比较两组差异。结果:与对照组相比,观察组谷丙转氨酶(ALT)、既往高血压的患病率、左心室室间隔厚度(IVSD)、左室壁厚度(LVPWD)比较差异有统计学意义(P<0.01)。结论:射血分数正常的心力衰竭患者较异常患者肝功能损伤较轻,既往高血压病史为LVEF正常CHF患者的危险因素,IVSD为其主要保护因素。 Objective: To investigate the difference in cardiac failure patients with left ventricular ejection fraction (LVEF)≥40%and 〈40%, and to evaluate influencing factors. Methods A total of 100 cardiac insufficiency patients with clinical sign at NYHA grade Ⅱ-Ⅳ were selected, including 48 patients with LVEF≥40% in observation group, and 52 patients〈40% in control group. Indexes were observed and compared. Results.- Compared with the control group, there were significant differences in alanine aminotransferase, past incidence of hypertension, left vebtricular interventricular septal defect (1VSD), left ventricular posterior wall thickness (P〈0.01). Oonclusions: The liver function injury of cardiac fail- ure patients with normal left ventricular ejection fraction is minor. Past history of hypertension is the risk factor, while IVSD is a protective factor.
作者 覃一玲
出处 《海南医学院学报》 CAS 2011年第11期1479-1481,共3页 Journal of Hainan Medical University
基金 海南医学院科研基金资助学报项目(0020110406)~~
关键词 心力衰竭 左心室射血分数 左心室室间隔厚度 左室壁厚度 Heart failure Left ventricular ejection fraction IVSD Influencing factor
  • 相关文献

参考文献6

二级参考文献44

  • 1罗景云,周宏研,孙明,王振华.高血压患者胰岛素受体与Ca^(2+),Mg^(2+)-ATP酶的变化[J].高血压杂志,1996,4(2):127-129. 被引量:3
  • 2董红志,秦勤,殷雅琴,赵炳让.血清胆红素和血脂的综合指数与冠心病的关系研究[J].中国分子心脏病学杂志,2004,4(5):271-274. 被引量:8
  • 3矢尾板裕幸,秦宇.舒张性心力衰竭治疗的现状和展望[J].日本医学介绍,2007,28(5):197-200. 被引量:10
  • 4Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study) [J].Arterioscler Thromb Vase Biol, 2002,22(7): 1162-1167.
  • 5Bosma P J, Vender Meer I M, Bakker C T, et al. UGTIA1 28 allele and coronary heart disease [.J]. Clin Chem, 2003,49 (7): 1180-1181.
  • 6Dudnik L B, Azyzova O A, Solovyova N P, et al. Primary biliary cirrhosis and coronary athero-sclerosis: protective antioxidant effect of bilirubin [J].Bull Exp Biol Med, 2008,145( 1 ) : 18-22.
  • 7Lingenhel A, Kollerits B, Schwaiger J P, et al. Serum bilirubin levels,UGT1Al polymorphisms and risk for coronary artery disease [J]. Exp Gerontol, 2008,43(12) : 1102-1107.
  • 8Vitek L, Novotny L, Sperl M, et al. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis[J]. Cerebrovasc Dis, 2006,21 (5-6) : 408-414.
  • 9Erdogan D, Gullu H, Yildirim E, et al. Low serum bilirubin levels are independently and inversely related to impaired flowmediated vasodilation and increased carotid intima-media thickness in both men and women [J]. Atherosclerosis, 2006,184(2):431- 437.
  • 10Uzui H, Harpf A, Liu M, et al type 3-matrix metallopro teinase Increased expression of membrane in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines [J] Circulation, 2002,106(24) :3024-3030.

共引文献18

同被引文献31

  • 1刘德桓,陈国英,陈文鑫.参附注射液治疗慢性心力衰竭的疗效观察[Z].第四届中医药继续教育高峰论坛暨中华中医药学会继续教育分会换届选举会议论文集[C].第四届中医药继续教育高峰论坛暨中华中医药学会继续教育分会换届选举会议,2011:334-338.
  • 2Mosterd A, Hoes AW. Clinical epidemiology of heart failure [ J ]. Heart, 2007, 93 ( 9 ) : 1137 - 1146.
  • 3张华明,严奉祥,李树楠,等.心脉隆对麻醉犬尿量和中心静脉压的影响[J].大理医学院学报,1992,1(1):1-4.
  • 4李树楠,张华明,杜一民.心脉隆对大鼠肠系膜微循环的效应观察[J].大理医学院学报,1992,1(1):10-13.
  • 5Maisel A. B - type natriuretie peptide levels: A potential novel " white count" for conges- tive heart failure [J]. J Card Fail, 2001, 7 (2): 183 -193.
  • 6Cheng V, Kazanagxa R, Garcia A, et al. A rapid bedside test for B - type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study [J]. J Am Coll Cardiol, 2001, 37 (2): 386 - 391.
  • 7Weber M, Hamm C. Role of B - type natri- uretic peptide (BNP) and NT - proBNP in clinical routine [ J ]. Heart, 2006, 92 (6) : 843 - 849.
  • 8Maurellet JD, Liu PT. B - type natriuretic peptide in the management of heart failure [J]. Hong Kong Med J, 2008, 14 (3): 216 -219.
  • 9无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3680
  • 10唐晓鸿.心脉隆注射液药理作用和治疗心力衰竭临床研究进展[J].中国新药杂志,2008,17(6):461-464. 被引量:105

引证文献4

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部